Paula F. Ypma

2.2k total citations
57 papers, 770 citations indexed

About

Paula F. Ypma is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paula F. Ypma has authored 57 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 15 papers in Genetics and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paula F. Ypma's work include Platelet Disorders and Treatments (17 papers), Hemophilia Treatment and Research (13 papers) and Multiple Myeloma Research and Treatments (9 papers). Paula F. Ypma is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Hemophilia Treatment and Research (13 papers) and Multiple Myeloma Research and Treatments (9 papers). Paula F. Ypma collaborates with scholars based in Netherlands, United States and Belgium. Paula F. Ypma's co-authors include Karina Meijer, Frank W.G. Leebeek, Johanna G. van der Bom, Jeroen Eikenboom, Evelien P. Mauser‐Bunschoten, Karin Fijnvandraat, Nic J.G.M. Veeger, Marten R. Nijziel, Nakisa Khorsand and Saskia le Cessie and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Paula F. Ypma

50 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula F. Ypma Netherlands	15	464	162	140	121	100	57	770
Henk J Adriaansen Netherlands	13	250 0.5×	177 1.1×	91 0.7×	60 0.5×	45 0.5×	29	665
Alex Gatt Malta	14	360 0.8×	146 0.9×	62 0.4×	190 1.6×	31 0.3×	39	750
Rhona Maclean United Kingdom	12	446 1.0×	189 1.2×	183 1.3×	166 1.4×	111 1.1×	23	838
P Beris Switzerland	13	589 1.3×	105 0.6×	306 2.2×	79 0.7×	33 0.3×	27	959
Yuan‐Bin Yu Taiwan	12	154 0.3×	49 0.3×	45 0.3×	52 0.4×	102 1.0×	35	458
Giampiera Bertolino Italy	14	223 0.5×	60 0.4×	93 0.7×	29 0.2×	16 0.2×	36	407
Orieji Illoh United States	8	262 0.6×	106 0.7×	125 0.9×	64 0.5×	57 0.6×	16	978
Véronique Le Cam‐Duchez France	13	346 0.7×	115 0.7×	89 0.6×	111 0.9×	19 0.2×	33	582
Elias Kyriakou Greece	16	217 0.5×	118 0.7×	120 0.9×	101 0.8×	40 0.4×	35	570
Simona Maria Siboni Italy	17	568 1.2×	71 0.4×	153 1.1×	52 0.4×	23 0.2×	55	839

Countries citing papers authored by Paula F. Ypma

Since Specialization

Citations

This map shows the geographic impact of Paula F. Ypma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula F. Ypma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula F. Ypma more than expected).

Fields of papers citing papers by Paula F. Ypma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula F. Ypma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula F. Ypma. The network helps show where Paula F. Ypma may publish in the future.

Co-authorship network of co-authors of Paula F. Ypma

This figure shows the co-authorship network connecting the top 25 collaborators of Paula F. Ypma. A scholar is included among the top collaborators of Paula F. Ypma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula F. Ypma. Paula F. Ypma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pastoor, Hester, Jeroen Eikenboom, Karin Fijnvandraat, et al.. (2025). Sexuality and bleeding in von Willebrand disease. Research and Practice in Thrombosis and Haemostasis. 9(2). 102712–102712.

Meer, Pieter F. van der, Paula F. Ypma, Jan Voorberg, et al.. (2025). Impact of platelet transfusions on plasma proteomes in controlled endotoxemia and in hemato‐oncological patients. Transfusion. 65(10). 1825–1838.

Nasserinejad, Kazem, Mark‐David Levin, Josien C. Regelink, et al.. (2024). Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes. HemaSphere. 8(7). e85–e85. 5 indexed citations

Sandoval, Diana Mūnoz, Pieter F. van der Meer, Jan Voorberg, et al.. (2024). Plasma proteomes of acute myeloid leukemia patients treated with transfusions reveal signatures of inflammation and hemostatic dysregulation. SHILAP Revista de lepidopterología. 9(1). 27–27. 1 indexed citations

Nasserinejad, Kazem, Mark‐David Levin, Josien C. Regelink, et al.. (2024). Dynamics of Geriatric Impairments Are Associated with Risk of Treatment Discontinuation in Elderly Patients with Multiple Myeloma. Blood. 144(Supplement 1). 3330–3330.

Jonge, Nick de, Jeroen J. W. M. Janssen, Paula F. Ypma, et al.. (2024). Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity. Supportive Care in Cancer. 32(9). 579–579. 2 indexed citations

Velden, Walter J. F. M. van der, Pieter R. Tuinman, Paula F. Ypma, et al.. (2023). Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia. New England Journal of Medicine. 388(21). 1956–1965. 26 indexed citations

Veringa, Anette, Roger J. M. Brüggemann, Lambert F. R. Span, et al.. (2023). Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial. International Journal of Antimicrobial Agents. 61(2). 106711–106711. 14 indexed citations

Cnossen, Marjon H., Cees Smit, Lize F. D. van Vulpen, et al.. (2023). Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study. Haemophilia. 29(5). 1191–1201.

10.

Coppens, Michiel, Saskia E.M. Schols, Roger E. G. Schutgens, et al.. (2022). Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study). SHILAP Revista de lepidopterología. 6(1). e60–e69. 2 indexed citations

11.

Sonneveld, Pieter, Sonja Zweegman, Michèle Cavo, et al.. (2022). Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma. HemaSphere. 6(10). e786–e786. 12 indexed citations

12.

Balen, Erna C. van, Cees Smit, Evelien P. Mauser‐Bunschoten, et al.. (2021). Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019. Journal of Thrombosis and Haemostasis. 19(10). 2394–2406. 23 indexed citations

13.

Mauser‐Bunschoten, Evelien P., Lize F. D. van Vulpen, Jeroen Eikenboom, et al.. (2020). Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018. Journal of Thrombosis and Haemostasis. 19(3). 645–653. 60 indexed citations

14.

Schutgens, Roger E. G., Britta A. P. Laros‐van Gorkom, Laurens Nieuwenhuizen, et al.. (2020). von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients. Thrombosis and Haemostasis. 120(7). 1056–1065. 5 indexed citations

15.

Minnema, Monique C., Kazem Nasserinejad, Bouke P. C. Hazenberg, et al.. (2019). Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial. Haematologica. 104(11). 2274–2282. 23 indexed citations

16.

Atiq, Ferdows, Karina Meijer, Jeroen Eikenboom, et al.. (2018). Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease. British Journal of Haematology. 182(1). 93–105. 34 indexed citations

17.

Khorsand, Nakisa, Reinier M. van Hest, Nic J.G.M. Veeger, et al.. (2018). Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3). BMJ Open. 8(3). e020764–e020764. 10 indexed citations

18.

Minnema, Monique C., Kazem Nasserinejad, Bouke P. C. Hazenberg, et al.. (2017). HOVON 104; FINAL RESULTS FROM A MULTICENTER, PROSPECTIVE PHASE II STUDY OF BORTEZOMIB BASED INDUCTION TREATMENT FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH DE NOVO AL AMYLOIDOSIS. Data Archiving and Networked Services (DANS). 1 indexed citations

19.

Ypma, Paula F., Pieter F. van der Meer, Nancy M. Heddle, et al.. (2016). A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial. BMJ Open. 6(1). e010156–e010156. 19 indexed citations

20.

Sanders, Yvonne, Britta A. P. Laros‐van Gorkom, Karina Meijer, et al.. (2014). von Willebrand disease and aging: an evolving phenotype. Journal of Thrombosis and Haemostasis. 12(7). 1066–1075. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact